论文部分内容阅读
Objective To explore the hematologic adverse effects in patients with renal cell carcinoma treated with sunitinib.Methods A total of 136 patients with advanced renal cell carcinoma were treated with
Objective To explore the hematologic adverse effects in patients with renal cell carcinoma treated with sunitinib. Methods A total of 136 patients with advanced renal cell carcinoma were treated with